NMN supplementation improved health parameters in mice | David Sinclair
Previous studies on nicotinamide mononucleotide, an NAD+ precursor, demonstrated that the molecule is effective in increasing NAD+ levels across multiple tissues while improving the outcome of a variety of age-related diseases in rodents. Current research on rodents indicates that nicotinamide mononucleotide improves frailty and heart function. Although these studies are promising in terms of rodent health, the questions of whether they work in humans and at what dose remain unanswered. In this clip, Dr. David Sinclair discusses the current state of research on nicotinamide mononucleotide.
Member support keeps us strong.
If you enjoy the fruits of , you can participate in helping us to keep improving it. Creating a pay-what-you-can subscription does just that! Plus, we throw in occasional member perks and, more importantly, churn out the best possible content without concerning ourselves with the wishes of any dark overlords.
Our website is 100% supported by people like you through this pay-what-you-can mechanism.
Fundamentals$15 / month
Loyal Fan$25 / month
Super Fan$50 / month
Power Supporter$125 / month
Heroic Supporter$250 / month